| abstract |
The present invention provides compounds of formula (I): or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, wherein all variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. The invention also relates to pharmaceutical compositions comprising these compounds and methods of using these compounds to treat thromboembolic and/or inflammatory disorders. |